drugset / Trial / NCT01527006

Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs

NCT01527006

Phase 2 Completed 63 enrolled Eisai Inc.
NaSingle-groupOpen-labelTreatment

Summary

This study is designed to evaluate the pharmacokinetics, efficacy, and safety of perampanel oral suspension on seizure frequency in pediatric participants maintained on one to three stable antiepileptic drugs

Timeline

Start
2012-01
Primary completion
2014-05
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Perampanel Small molecule 0.18 mg/kg Oral